USD 33.51
(-1.63%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 445 Thousand USD | -5.12% |
2022 | 469 Thousand USD | -14.73% |
2021 | 550 Thousand USD | 119.59% |
2020 | -2.8 Million USD | 19.45% |
2019 | -3.48 Million USD | -24.46% |
2018 | -2.8 Million USD | -113.0% |
2017 | -1.31 Million USD | -49.94% |
2016 | -877 Thousand USD | 31.38% |
2015 | -1.27 Million USD | -260.0% |
2014 | -355 Thousand USD | -35499900.0% |
2013 | -1.00 USD | 0.0% |
2012 | - USD | 0.0% |
2011 | - USD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 385 Thousand USD | -5.64% |
2024 Q1 | 408 Thousand USD | -8.31% |
2024 Q3 | 380 Thousand USD | -1.3% |
2023 FY | 445 Thousand USD | -5.12% |
2023 Q2 | 476 Thousand USD | -7.03% |
2023 Q3 | 439 Thousand USD | -7.77% |
2023 Q4 | 445 Thousand USD | 1.37% |
2023 Q1 | 512 Thousand USD | 9.17% |
2022 Q2 | 524 Thousand USD | -11.93% |
2022 Q1 | 595 Thousand USD | 8.18% |
2022 Q4 | 469 Thousand USD | -8.22% |
2022 FY | 469 Thousand USD | -14.73% |
2022 Q3 | 511 Thousand USD | -2.48% |
2021 Q3 | 1.78 Million USD | 4.26% |
2021 Q1 | 639 Thousand USD | 122.76% |
2021 FY | 550 Thousand USD | 119.59% |
2021 Q2 | 1.71 Million USD | 168.39% |
2021 Q4 | 550 Thousand USD | -69.24% |
2020 Q4 | -2.8 Million USD | -412.0% |
2020 FY | -2.8 Million USD | 19.45% |
2020 Q1 | -1.58 Million USD | 54.65% |
2020 Q2 | -982 Thousand USD | 37.89% |
2020 Q3 | 900 Thousand USD | 191.65% |
2019 FY | -3.48 Million USD | -24.46% |
2019 Q1 | -2.53 Million USD | 9.57% |
2019 Q2 | -3.5 Million USD | -38.53% |
2019 Q3 | -3.27 Million USD | 6.78% |
2019 Q4 | -3.48 Million USD | -6.57% |
2018 Q4 | -2.8 Million USD | -12.94% |
2018 Q1 | - USD | 100.0% |
2018 Q2 | -1.85 Million USD | 0.0% |
2018 Q3 | -2.48 Million USD | -34.05% |
2018 FY | -2.8 Million USD | -113.0% |
2017 Q3 | -1.47 Million USD | -66.89% |
2017 Q1 | - USD | 100.0% |
2017 FY | -1.31 Million USD | -49.94% |
2017 Q4 | -1.31 Million USD | 10.97% |
2017 Q2 | -885 Thousand USD | 0.0% |
2016 Q2 | -607 Thousand USD | -1.34% |
2016 FY | -877 Thousand USD | 31.38% |
2016 Q4 | -877 Thousand USD | 2.23% |
2016 Q1 | -599 Thousand USD | 53.13% |
2016 Q3 | -897 Thousand USD | -47.78% |
2015 FY | -1.27 Million USD | -260.0% |
2015 Q4 | -1.27 Million USD | -191.12% |
2015 Q3 | -439 Thousand USD | -67.56% |
2015 Q2 | -262 Thousand USD | 26.4% |
2015 Q1 | -356 Thousand USD | -0.28% |
2014 Q4 | -355 Thousand USD | 0.0% |
2014 Q2 | 1.00 USD | 0.0% |
2014 Q3 | - USD | -100.0% |
2014 FY | -355 Thousand USD | -35499900.0% |
2014 Q1 | 1.00 USD | 200.0% |
2013 FY | -1.00 USD | 0.0% |
2013 Q2 | - USD | 100.0% |
2013 Q3 | - USD | 0.0% |
2013 Q4 | -1.00 USD | 0.0% |
2013 Q1 | -2.6 Million USD | 0.0% |
2012 Q4 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
2011 FY | - USD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Accelerate Diagnostics, Inc. | 3.31 Million USD | 86.556% |
BrainsWay Ltd. | 3.71 Million USD | 88.028% |
Cerus Corporation | 39.86 Million USD | 98.884% |
Envoy Medical, Inc. | 1.4 Million USD | 68.305% |
electroCore, Inc. | 2.16 Million USD | 79.398% |
Helius Medical Technologies, Inc. | 457 Thousand USD | 2.626% |
IceCure Medical Ltd | 2.27 Million USD | 80.44% |
Inogen, Inc. | 21.84 Million USD | 97.962% |
OrthoPediatrics Corp. | 105.85 Million USD | 99.58% |
Lucid Diagnostics Inc. | 278 Thousand USD | -60.072% |
Monogram Orthopaedics, Inc. | 1.00 USD | -44499900.0% |
MaxCyte, Inc. | 12.22 Million USD | 96.361% |
NeuroOne Medical Technologies Corporation | 1.72 Million USD | 74.228% |
Nexalin Technology, Inc. | 156.42 Thousand USD | -184.49% |
Orthofix Medical Inc. | 222.16 Million USD | 99.8% |
PAVmed Inc | 1.01 Million USD | 56.244% |
Rapid Micro Biosystems, Inc. | 19.96 Million USD | 97.771% |
RxSight, Inc. | 17.42 Million USD | 97.446% |
Sight Sciences, Inc. | 7.84 Million USD | 94.33% |
SI-BONE, Inc. | 20.24 Million USD | 97.802% |
TELA Bio, Inc. | 13.16 Million USD | 96.619% |
Treace Medical Concepts, Inc. | 29.24 Million USD | 98.478% |
Vivos Therapeutics, Inc. | 1.00 USD | -44499900.0% |
Acutus Medical, Inc. | 4.27 Million USD | 89.598% |
Talis Biomedical Corporation | - USD | -Infinity% |
Spectral AI, Inc. | 230 Thousand USD | -93.478% |
Nano-X Imaging Ltd. | 2.35 Million USD | 81.112% |
CVRx, Inc. | 10.98 Million USD | 95.948% |
DIH Holding US, Inc. Warrants | - USD | -Infinity% |
PetVivo Holdings, Inc. | 390.07 Thousand USD | -14.08% |
Bioventus Inc. | 91.33 Million USD | 99.513% |
Venus Concept Inc. | 28.67 Million USD | 98.448% |
TriSalus Life Sciences, Inc. | 2.54 Million USD | 82.515% |
LivaNova PLC | 147.88 Million USD | 99.699% |
908 Devices Inc. | 14.93 Million USD | 97.021% |
Alphatec Holdings, Inc. | 136.84 Million USD | 99.675% |
Nemaura Medical Inc. | 1.75 Million USD | 74.642% |
NeuroPace, Inc. | 11.21 Million USD | 96.032% |
LENSAR, Inc. | 15.68 Million USD | 97.164% |
Apyx Medical Corporation | 9.92 Million USD | 95.515% |
Cutera, Inc. | 72.1 Million USD | 99.383% |
STRATA Skin Sciences, Inc. | 2.67 Million USD | 83.352% |
BioSig Technologies, Inc. | -103 Thousand USD | 532.039% |
Anika Therapeutics, Inc. | 46.38 Million USD | 99.041% |
ClearPoint Neuro, Inc. | 7.91 Million USD | 94.375% |
Integra LifeSciences Holdings Corporation | 389.6 Million USD | 99.886% |
Axonics, Inc. | 79.94 Million USD | 99.443% |
Outset Medical, Inc. | 49.21 Million USD | 99.096% |
IRIDEX Corporation | 9.9 Million USD | 95.508% |
PROCEPT BioRobotics Corporation | 39.75 Million USD | 98.881% |
IRadimed Corporation | 12.82 Million USD | 96.529% |
Tivic Health Systems, Inc. | 756 Thousand USD | 41.138% |
INVO Bioscience, Inc. | 264.5 Thousand USD | -68.238% |
Telesis Bio, Inc. | 4.02 Million USD | 88.944% |
Viemed Healthcare, Inc. | 4.6 Million USD | 90.335% |
Varex Imaging Corporation | 277.5 Million USD | 99.84% |
Quipt Home Medical Corp. | 18.32 Million USD | 97.572% |
Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
Pulmonx Corporation | 16.74 Million USD | 97.342% |
Dynatronics Corporation | 5.59 Million USD | 92.045% |
Modular Medical, Inc. | - USD | -Infinity% |
ReShape Lifesciences Inc. | 3.74 Million USD | 88.105% |
InMode Ltd. | 45.09 Million USD | 99.013% |
Bruker Corporation | 968.3 Million USD | 99.954% |
Cytosorbents Corporation | 3.68 Million USD | 87.908% |
DexCom, Inc. | 559.6 Million USD | 99.92% |
Align Technology, Inc. | 296.9 Million USD | 99.85% |
Viveve Medical, Inc. | 1.47 Million USD | 69.769% |
ZimVie Inc. | 79.6 Million USD | 99.441% |
Movano Inc. | 1.51 Million USD | 70.588% |
Cytek Biosciences, Inc. | 60.87 Million USD | 99.269% |
Nexalin Technology, Inc. | 156.42 Thousand USD | -184.49% |
DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
Tandem Diabetes Care, Inc. | 157.93 Million USD | 99.718% |
Profound Medical Corp. | 6.95 Million USD | 93.6% |
Insulet Corporation | 402.6 Million USD | 99.889% |
enVVeno Medical Corporation | - USD | -Infinity% |
Surmodics, Inc. | 14.83 Million USD | 97.001% |
iCAD, Inc. | 917 Thousand USD | 51.472% |
Nuwellis, Inc. | 1.99 Million USD | 77.717% |
Biotricity, Inc. | 1.87 Million USD | 76.322% |
iRhythm Technologies, Inc. | 13.97 Million USD | 96.815% |
Aethlon Medical, Inc. | - USD | -Infinity% |
InspireMD, Inc. | 2.1 Million USD | 78.87% |
PAVmed Inc. | 1.01 Million USD | 56.244% |
BIOLASE, Inc. | 11.43 Million USD | 96.108% |
Beyond Air, Inc. | 2.12 Million USD | 79.079% |
FONAR Corporation | 2.71 Million USD | 83.612% |
AxoGen, Inc. | 23.02 Million USD | 98.067% |
Vivani Medical, Inc. | - USD | -Infinity% |
Tactile Systems Technology, Inc. | 22.52 Million USD | 98.025% |
Inari Medical, Inc. | 42.9 Million USD | 98.963% |
UFP Technologies, Inc. | 70.19 Million USD | 99.366% |
QT Imaging Holdings, Inc. | - USD | -Infinity% |
Heart Test Laboratories, Inc. | 629.17 Thousand USD | 29.273% |
Tenon Medical, Inc. | 554 Thousand USD | 19.675% |
Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
Co-Diagnostics, Inc. | 1.66 Million USD | 73.269% |
AdaptHealth Corp. | 113.64 Million USD | 99.608% |
Sintx Technologies, Inc. | 888 Thousand USD | 49.887% |
NanoVibronix, Inc. | 2.73 Million USD | 83.712% |
Quanterix Corporation | 22.36 Million USD | 98.01% |
Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
Sensus Healthcare, Inc. | 14.84 Million USD | 97.003% |
Pacific Biosciences of California, Inc. | 56.67 Million USD | 99.215% |
TransMedics Group, Inc. | 44.23 Million USD | 98.994% |
ReWalk Robotics Ltd. | 5.65 Million USD | 92.128% |
NeuroMetrix, Inc. | 1.55 Million USD | 71.464% |
Hyperfine, Inc. | 6.58 Million USD | 93.239% |
Establishment Labs Holdings Inc. | 79.93 Million USD | 99.443% |
Biomerica, Inc. | 2.37 Million USD | 81.271% |
Bone Biologics Corporation | -328.84 Thousand USD | 235.323% |
AVITA Medical, Inc. | 3.12 Million USD | 85.744% |
Bluejay Diagnostics, Inc. | - USD | -Infinity% |
Silk Road Medical, Inc | 29.87 Million USD | 98.511% |